Agenus (AGEN) 10-Q2015 Q1 Quarterly report

Filed: 1 May 15, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: aim, amicably, Andrew, assimilate, began, brain, carmustine, Celexion, classified, CMV, committee, conjunction, convenience, customary, destruction, disable, disagreement, Dohme, driven, duration, eradicate, evade, exit, Factor, formal, global, hematology, holding, immaterial, Incyte, induced, innovative, Ireland, joined, joint, jointly, library, magnitude, median, minimal, mutual, nivolumab, nominate, nonrefundable, older, Parsa, penalty, pivotal, placebo, play, point, preceding, prioritize, promissory, prophylactic, ready, repay, representation, Representative, Robert, satisfactorily, SECANT, serve, settled, shareholder, Sharpe, simple, steering, Stein, stimulate, susceptible, temozolmide, thereof, tiered, UC, unclear, uncured, undergoing, underway, unexpectedly, unrealized, Vischer, yeast

Removed: accommodate, account, accrue, adherence, affirmative, AGEN, AI, antagonist, antigenic, Aquila, arrangement, array, ASC, assessing, assumed, authority, authorized, Avastin, bark, base, bearing, bid, blind, booster, carryforward, cellular, central, chemotherapy, Chile, clinic, commenced, conferred, consolidate, continuance, contractual, contrast, convert, converted, covenant, cure, debilitating, declare, dedicate, deducting, defer, delisted, delisting, deteriorate, diverted, dollar, double, enabled, enabling, enrolled, envision, establishing, evergreen, extracted, faced, Famvir, finalized, fingerprint, foreclose, forma, funded, Genocea, Gliadel, Gmbh, hampered, healthy, heavily, illustrative, impinge, incurring, infected, Innocell, insolvency, institution, integrating, intermediate, kidney, largest, leave, Lender, lien, lieu, line, listing, lower, marketed, merge, minimum, mix, molecular, molecule, multicenter, native, November, optimization, payer, precise, preclinical, preliminary, prepayment, pro, proceed, purify, purifying, purport, Quillaja, radiation, rapid, RCC, recurrence, regional, regulate, reimbursed, reimbursement, released, relief, replicate, reprogram, requirement, restrictive, retired, returned, role, salary, saponaria, scheduled, secured, selected, shedding, shift, simplex, skill, stable, staffing, statistically, studied, subsequent, supplemental, supplied, symbol, tangible, Temodar, temperate, territory, therapy, top, track, translate, tree, underwritten, unissued, unpaid, vaccination, validated, Valtrex, varied, Vical, warm, warrant, widely, wider, Yervoy

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

AGEN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Agenus Inc. (the “Company”) for the quarterly period ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned to his/her knowledge hereby certifies, pursuant to 18 U.S.C. Section 1350, that:


(i)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and


(ii)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



	/s/ GARO H. ARMEN, Ph.D.
	Garo H. Armen, Ph.d.
	Chief Executive Officer and Principal Executive Officer

	/s/ CHRISTINE M. KLASKIN
	Christine M. Klaskin
	VP, Finance and Principal Financial Officer

Date: May 1, 2015

A signed original of this written statement required by Section 906 has been provided to the Company. and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Report and should not be considered filed as part of the Report.